Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Thomas Jefferson University
Incyte Corporation
Incyte Corporation
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Incyte Corporation
Celgene
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
American Regent, Inc.
City of Hope Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Stemline Therapeutics, Inc.
Celgene
Incyte Corporation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Celgene
Asana BioSciences
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Alabama at Birmingham
Incyte Corporation
University of Utah
Hoffmann-La Roche
Geron Corporation
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
Icahn School of Medicine at Mount Sinai
Northwestern University
CTI BioPharma
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Gilead Sciences
NYU Langone Health
Daiichi Sankyo
Novartis
Fred Hutchinson Cancer Center
Mayo Clinic
Italfarmaco